Scott Thomas Jackson - 20 May 2025 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Director
Signature
Beth A. Smith, Attorney-in-fact
Issuer symbol
MGNX
Transactions as of
20 May 2025
Net transactions value
$0
Form type
4
Filing time
22 May 2025, 16:03:01 UTC
Previous filing
03 Jun 2024
Next filing
13 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jackson Scott Thomas Director 9704 MEDICAL CENTER DRIVE, ROCKVILLE Beth A. Smith, Attorney-in-fact 22 May 2025 0001566617

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise +6,500 +144% 11,000 20 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Restricted Stock Unit Options Exercise $0 -6,500 -100% $0.000000 0 20 May 2025 Common Stock 6,500 $0.000000 Direct F1, F2
transaction MGNX Restricted Stock Unit Award $0 +3,750 $0.000000 3,750 21 May 2025 Common Stock 3,750 $0.000000 Direct F1, F3
transaction MGNX Stock Option (right to buy) Award $0 +22,000 $0.000000 22,000 21 May 2025 Common Stock 22,000 $1.49 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
F2 The RSUs vested on May 20, 2025, which was one day prior to the Issuer's 2025 Annual Meeting of Stockholders held on May 21, 2025.
F3 The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier
F4 The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.